Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)

NCT03219671 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Classic Kaposi Sarcoma

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab

Sponsor

Alona Zer

Collaborators

[object Object]